"Chimeric Therapeutics is leading a very aggressive push to get a clinic study and now is in the process of getting regulatory approval and hopefully by the end of this year or early of next year we could be at the stage of enrolling the patients. That is the hope." - Dr Xianxin Hua
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)